Antibody-mediated Rejection Market is driven by Rising Transplants
Antibody-mediated rejection assays, therapeutics, and monitoring tools have become critical for early detection and treatment of organ rejection events. Products such as complement inhibitors, anti-CD20 monoclonal antibodies, and novel biosensors offer improved graft survival, lower hospital readmission rates, and enhanced patient quality of life. These immunomodulatory therapies and diagnostic...
0 Comments 0 Shares 52 Views 0 Reviews